Navigation Links
Christmas trees to yield key Tamiflu ingredient

Biolyse Pharma Corp., a closely held Canadian company that extracts chemicals from plants, plans to use used Christmas trees to extract the chemical for making Tamiflu, the drug that treat bird flu.//

The trees contain shikimic acid in their pine, spruce and fir needles, Ontario-based Biolyse said today in a statement. The acid is used in Roche Holding AG's Tamiflu and is mainly extracted from star anise trees in China, Biolyse said.

Tamiflu is being perceived as the first line of defence against a possible pandemic outbreak of bird flu, which has been devastating chicken populations across Southeast Asia and parts of Europe.

So far, the H5N1 virus, which usually strikes people in close contact with diseased fowl or their droppings, has infected an estimated 130 people, killing 70. The worry is that H5N1 will undergo a genetic mutation with a human seasonal influenza virus, morphing into a deadly strain that could jump between people like the common cold.

After being rejected as a Tamiflu supplier by Swiss drug maker F. Hoffmann-La Roche Ltd., which has a patent for the drug, Biolyse thought of making shikimik acid. The price of shikimik acid has soared to more than $500 (U.S.) a kg from $45 in the past 12 months on shortages of Tamiflu and skyrocketing demand, with various countries clamouring to stockpile the drug.

Biolyse specializes in extracting chemicals from plants and biomaterials at its plant in St. Catharines, Ontario. Now makes a generic version of the cancer drug paclitaxel from yew trees.

“Our research has shown that 2-to-3 per cent of the biomass from various pine, spruce and fir trees is extractible shikimic acid,” Biolyse principal Claude Mercure said yesterday.

Once the process becomes commercialized, the company is aiming to eventually produce 1 one to three tons of shikimic acid a month.

To get started, next month it will receive some 500,000 Christmas trees to be donated by Toronto-based Gro-Bark, a forestry recycling company.

Most shikimic acid is now extracted from star anise, the fruit of a slow-growing evergreen in China, which is harvested for several months each year. That's why Roche's production of Tamiflu takes about 12 months and there isn't nearly enough of the drug to go around for government stockpiling.

Biolyse hopes its process will be more viable as the particular species of pine, spruce and fir that it is working with are far more abundant than the seedlings of star anise.

Biolyse has no plans to make Tamiflu unless Ottawa grants compulsory licences under the Patent Act in a national emergency. In such a case, he said the company could produce the drug in five weeks.

In countries where Roche's patents on Tamiflu are not recognized, such as the Philippines and Thailand, Biolyse is in discussions to sell shikimic acid and provide technical assistance to manufacture the drug for use in that country.


'"/>




Related medicine news :

1. Turkey Is Listed In The Christmas Meal Despite Bird Flu Scare
2. Christmas turkey? Anyone?
3. Christmas, Carols And Unique Indian Christianity
4. Toy Story Turns Bitter-Christmas Toys, No Music to the Ears!
5. Scots Demand Best Quality Treatment For COPD As Christmas Gift
6. Reach Out at Christmas
7. Celebrating Christmas With Wine – The Elixir of the God
8. Mistletoe Is Good For Christmas Decorations, Not For Cancer
9. The Best Christmas Gift
10. How trees affect sun exposure
11. Chemical in Gila monsters saliva yields Alzheimer drug
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/24/2016)... ... June 24, 2016 , ... EB Medicine presented ... in Emergency Medicine conference in Ponte Vedra Beach, FL. The awards honor the ... Emergency Medicine Practice and Pediatric Emergency Medicine Practice. , “With this award, ...
(Date:6/24/2016)... ... June 24, 2016 , ... Strategic Capital Partners, LLC ... by obtaining investment capital for emerging technology companies. SCP has delivered investment ... resulted in more than a million dollars of capital investment for five companies. ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... induced pluripotent stem (iPS) cells and other difficult to transfect cells, announces its ... The PluriQ™ G9™ Gene Editing System is a complete system for ...
(Date:6/24/2016)... ... June 24, 2016 , ... To succeed under value-based payments, ... are unsure how to move forward, given the need to sustain current operations. ... tailored to an organization’s specific needs. , PYA Principal Martie Ross states, “Healthcare ...
(Date:6/24/2016)... ... 24, 2016 , ... SpiritQuest Sedona Retreats, located in Arizona has re-located to ... vortex sites: Cathedral Rock, Airport Mesa, and Boynton Canyon. The new retreat center ... as well as the Sedona Rouge, both popular accommodations for SpiritQuest clients. The ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... Research and Markets has announced the addition ... Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality (Filler, Binder, ... Forecast to 2021" report to their offering. ... excipients market is projected to reach USD 8.1 Billion ... forecast period 2016 to 2021. The ...
(Date:6/23/2016)... Research and Markets has announced the ... report to their offering. ... favourable commercial environment for MedImmune to enter. The US ageing ... serve to drive considerable growth for effective anti-influenza medications. The ... sales considerably, but development is still in its infancy. ...
(Date:6/23/2016)... , June 23, 2016 ... Oticon , industry leaders in advanced ... launch of Oticon Opn ™, the world,s first ... of possibilities for IoT devices.      (Photo: ... Oticon introduces a number of ,world firsts,: ...
Breaking Medicine Technology: